Masud Husain
doi : 10.1093/brain/awad140
Brain, Volume 146, Issue 6, June 2023, Pages 2199–2200
Gerald Wiest
doi : 10.1093/brain/awad149
Brain, Volume 146, Issue 6, June 2023, Pages 2201–2202
Sara K Inati, Kareem A Zaghloul
doi : 10.1093/brain/awad141
Brain, Volume 146, Issue 6, June 2023, Pages 2203–2205
Eric Minikel Vallabh, Sonia M Vallabh
doi : 10.1093/brain/awad143
Brain, Volume 146, Issue 6, June 2023, Pages 2206–2207
Kyan Younes, Elizabeth C Mormino
doi : 10.1093/brain/awad154
Brain, Volume 146, Issue 6, June 2023, Pages 2208–2210
Kyan Younes, Sharon J Sha
doi : 10.1093/brain/awad151
Brain, Volume 146, Issue 6, June 2023, Pages 2211–2213
Michal T Kucewicz, Gregory A Worrell, Nikolai Axmacher
doi : 10.1093/brain/awac435
Brain, Volume 146, Issue 6, June 2023, Pages 2214–2226
Modulation of cognitive functions supporting human declarative memory is one of the grand challenges of neuroscience, and of vast importance for a variety of neuropsychiatric, neurodegenerative and neurodevelopmental diseases.
Miriam Mistretta, Andrea Farini, Yvan Torrente, Chiara Villa
doi : 10.1093/brain/awad014
Brain, Volume 146, Issue 6, June 2023, Pages 2227–2240
Neurodegenerative diseases are a major global health burden particularly with the increasing ageing population. Hereditary predisposition and environmental risk factors contribute to the heterogeneity of existing pathological phenotypes.
Paul J Harrison, Maxime Taquet
doi : 10.1093/brain/awad008
Brain, Volume 146, Issue 6, June 2023, Pages 2241–2247
Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following Coronavirus disease 2019 [COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection)], but many questions remain.
John M Bernabei, Adam Li, Andrew Y Revell, Rachel J Smith, Kristin M Gunnarsdottir, Ian Z Ong, Kathryn A Davis, Nishant Sinha, Sridevi Sarma, Brian Litt
doi : 10.1093/brain/awad007
Brain, Volume 146, Issue 6, June 2023, Pages 2248–2258
Over the past 10 years, the drive to improve outcomes from epilepsy surgery has stimulated widespread interest in methods to quantitatively guide epilepsy surgery from intracranial EEG (iEEG).
Mateusz W Kucharczyk, Francesca Di Domenico, Kirsty Bannister
doi : 10.1093/brain/awad002
Brain, Volume 146, Issue 6, June 2023, Pages 2259–2267
The CNS houses naturally occurring pathways that project from the brain to modulate spinal neuronal activity.
Hannah M Edwards, Clare E Wallace, Woodrow D Gardiner, Brookelyn M Doherty, Ryan T Harrigan, Kayla M Yuede, Carla M Yuede, John R Cirrito
doi : 10.1093/brain/awad052
Brain, Volume 146, Issue 6, June 2023, Pages 2268–2274
The risk of developing Alzheimer’s disease is mediated by a combination of genetics and environmental factors, such as stress, sleep abnormalities and traumatic brain injury.
Hana Florian, Deli Wang, Steven E Arnold, Mercè Boada, Qi Guo, Ziyi Jin, Hui Zheng, Nahome Fisseha, Hari Varun Kalluri, Beatrice Rendenbach-Mueller, Kumar Budur, Michael Gold on behalf of the Aware Investigators
doi : 10.1093/brain/awad024
Brain, Volume 146, Issue 6, June 2023, Pages 2275–2284
Tau accumulation in patients with Alzheimer’s disease tracks closely with cognitive decline and plays a role in the later stages of disease progression. This phase 2 study evaluated the safety and efficacy of tilavonemab, an anti-tau monoclonal antibody, in patients with early Alzheimer’s disease.
Ashish R Deshwar, Cheryl Cytrynbaum, Harsha Murthy, Jessica Zon, David Chitayat, Jonathan Volpatti, Ruth Newbury-Ecob, Sian Ellard, Hana Lango Allen, Emily P Yu, Ramil Noche, Suzi Walker, Stephen W Scherer, Sonal Mahida, Christopher M Elitt, Gaël Nicolas, Alice Goldenberg, Pascale Saugier-Veber, Francois Lecoquierre, Ivana Dabaj, Hannah Meddaugh, Michael Marble, Kim M Keppler-Noreuil, Lucy Drayson, Kristin W Barañano, Anna Chassevent, Katie Agre, Pascaline Létard, Frederic Bilan, Gwenaël Le Guyader, Annie Laquerrière, Keri Ramsey, Lindsay Henderson, Lauren Brady, Mark Tarnopolsky, Matthew Bainbridge, Jennifer Friedman, Yline Capri, Larissa Athayde, Fernando Kok, Juliana Gurgel-Giannetti, Luiza L P Ramos, Susan Blaser, James J Dowling, Rosanna Weksberg
doi : 10.1093/brain/awac461
Brain, Volume 146, Issue 6, June 2023, Pages 2285–2297
The blood–brain barrier ensures CNS homeostasis and protection from injury. Claudin-5 (CLDN5), an important component of tight junctions, is critical for the integrity of the blood–brain barrier.
Sarah B Thomson, Anouk Stam, Cynthia Brouwers, Valentina Fodale, Alberto Bresciani, Michael Vermeulen, Sara Mostafavi, Terri L Petkau, Austin Hill, Andrew Yung, Bretta Russell-Schulz, Piotr Kozlowski, Alex MacKay, Da Ma, Mirza Faisal Beg, Melvin M Evers, Astrid Vallès, Blair R Leavitt
doi : 10.1093/brain/awac458
Brain, Volume 146, Issue 6, June 2023, Pages 2298–2315
Huntingtin (HTT)-lowering therapies show great promise in treating Huntington’s disease. We have developed a microRNA targeting human HTT that is delivered in an adeno-associated serotype 5 viral vector (AAV5-miHTT), and here use animal behaviour, MRI, non-invasive proton magnetic resonance spectroscopy and striatal RNA sequencing as outcome measures in preclinical mouse studies of AAV5-miHTT.
Vilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, Jim Stankovich, Pavlina Kleinova, Fuencisla Matesanz, Daniel Hui, Sara Eichau, Mark Slee, Jeannette Lechner-Scott, Rodney Lea, Trevor J Kilpatrick, Tomas Kalincik, Philip L De Jager, Ashley Beecham, Jacob L McCauley, Bruce V Taylor, Steve Vucic, Louise Laverick, Karolina Vodehnalova, Maria-Isabel GarcÃa-Sanchéz, Antonio Alcina, Anneke van der Walt, Eva Kubala Havrdova, Guillermo Izquierdo, Nikolaos Patsopoulos, Dana Horakova, Helmut Butzkueven
doi : 10.1093/brain/awac449
Brain, Volume 146, Issue 6, June 2023, Pages 2316–2331
Multiple sclerosis is a leading cause of neurological disability in adults. Heterogeneity in multiple sclerosis clinical presentation has posed a major challenge for identifying genetic variants associated with disease outcomes.
Catarina Osório, Joshua J White, Heiling Lu, Gerrit C Beekhof, Francesca Romana Fiocchi, Charlotte A Andriessen, Stephanie Dijkhuizen, Laura Post, Martijn Schonewille
doi : 10.1093/brain/awac422
Brain, Volume 146, Issue 6, June 2023, Pages 2332–2345
Spinocerebellar ataxias are neurodegenerative diseases, the hallmark symptom of which is the development of ataxia due to cerebellar dysfunction. Purkinje cells, the principal neurons of the cerebellar cortex, are the main cells affected in these disorders, but the sequence of pathological events leading to their dysfunction is poorly understood.
Rebekah Koppenol, André Conceição, Inês T Afonso, Ricardo Afonso-Reis, Rafael G Costa, Sandra Tomé, Diogo Teixeira, Joana Pinto da Silva, José Miguel Côdesso, David V C Brito, Liliana Mendonça, Adriana Marcelo, LuÃs Pereira de Almeida, Carlos A Matos, Clévio Nóbrega
doi : 10.1093/brain/awac473
Brain, Volume 146, Issue 6, June 2023, Pages 2346–2363
Polyglutamine diseases are a group of neurodegenerative disorders caused by an abnormal expansion of CAG repeat tracts in the codifying regions of nine, otherwise unrelated, genes.
Chujun Wu, Mengwen Wang, Xingao Wang, Wei Li, Shaowu Li, Bin Chen, Songtao Niu, Hongfei Tai, Hua Pan, Zaiqiang Zhang
doi : 10.1093/brain/awac426
Brain, Volume 146, Issue 6, June 2023, Pages 2364–2376
Genetic leukoencephalopathies (gLEs) are a highly heterogeneous group of rare genetic disorders.
Davide Giampiccolo, Lawrence P Binding, Lorenzo Caciagli, Roman Rodionov, Chris Foulon, Jane de Tisi, Alejandro Granados, Roisin Finn, Debayan Dasgupta, Fenglai Xiao, Beate Diehl, Emma Torzillo, Jan Van Dijk, Peter N Taylor, Matthias Koepp, Andrew W McEvoy, Sallie Baxendale, Fahmida Chowdhury, John S Duncan, Anna Miserocchi
doi : 10.1093/brain/awad085
Brain, Volume 146, Issue 6, June 2023, Pages 2377–2388
Around 50% of patients undergoing frontal lobe surgery for focal drug-resistant epilepsy become seizure free post-operatively; however, only about 30% of patients remain seizure free in the long-term. Early seizure recurrence is likely to be caused by partial resection of the epileptogenic lesion, whilst delayed seizure recurrence can occur even if the epileptogenic lesion has been completely excised.
Carolina Ferreira-Atuesta, Jane de Tisi, Andrew W McEvoy, Anna Miserocchi, Jean Khoury, Ruta Yardi, Deborah T Vegh, James Butler, Hamin J Lee, Victoria Deli-Peri, Yi Yao, Feng-Peng Wang, Xiao-Bin Zhang, Lubna Shakhatreh, Pakeeran Siriratnam, Andrew Neal, Arjune Sen, Maggie Tristram, Elizabeth Varghese, Wendy Biney, William P Gray, Ana Rita Peralta, Alexandre Rainha-Campos, António J C Gonçalves-Ferreira, José Pimentel, Juan Fernando Arias, Samuel Terman, Robert Terziev, Herm J Lamberink, Kees P J Braun, Willem M Otte, Fergus J Rugg-Gunn, Walter Gonzalez, Carla Bentes, Khalid Hamandi, Terence J O’Brien, Piero Perucca, Chen Yao, Richard J Burman, Lara Jehi, John S Duncan, Josemir W Sander, Matthias Koepp, Marian Galovic
doi : 10.1093/brain/awac437
Brain, Volume 146, Issue 6, June 2023, Pages 2389–2398
More than half of adults with epilepsy undergoing resective epilepsy surgery achieve long-term seizure freedom and might consider withdrawing antiseizure medications. We aimed to identify predictors of seizure recurrence after starting postoperative antiseizure medication withdrawal and develop and validate predictive models.
Nicola Masala, Martin Pofahl, André N Haubrich, Khondker Ushna Sameen Islam, Negar Nikbakht, Maryam Pasdarnavab, Kirsten Bohmbach, Kunihiko Araki, Fateme Kamali, Christian Henneberger, Kurtulus Golcuk, Laura A Ewell, Sandra Blaess, Tony Kelly, Heinz Beck
doi : 10.1093/brain/awac455
Brain, Volume 146, Issue 6, June 2023, Pages 2399–2417
Memory deficits are a debilitating symptom of epilepsy, but little is known about mechanisms underlying cognitive deficits. Here, we describe a Na+ channel-dependent mechanism underlying altered hippocampal dendritic integration, degraded place coding and deficits in spatial memory.
Gashirai K Mbizvo, Christian Schnier, Colin R Simpson, Susan E Duncan, Richard F M Chin
doi : 10.1093/brain/awac463
Brain, Volume 146, Issue 6, June 2023, Pages 2418–2430
This study aimed to develop a risk prediction model for epilepsy-related death in adults.
Yoko Ikoma, Yusuke Takahashi, Daichi Sasaki, Ko Matsui
doi : 10.1093/brain/awac499
Brain, Volume 146, Issue 6, June 2023, Pages 2431–2442
It is usually assumed that individuals rest during sleep. However, coordinated neural activity that presumably requires high energy consumption is increased during REM sleep.
Christoph Sperber, Laura Gallucci, Roza Umarova
doi : 10.1093/brain/awac443
Brain, Volume 146, Issue 6, June 2023, Pages 2443–2452
For years, dissociation studies on neurological single-case patients with brain lesions were the dominant method to infer fundamental cognitive functions in neuropsychology. In contrast, the association between deficits was considered to be of less epistemological value.
Esther Henriet, Elodie M Martin, Pauline Jubin, Dominique Langui, Abdelkrim Mannioui, Bruno Stankoff, Catherine Lubetzki, Arseny Khakhalin, Bernard Zalc
doi : 10.1093/brain/awad051
Brain, Volume 146, Issue 6, June 2023, Pages 2453–2463
In multiple sclerosis, while remarkable progress has been accomplished to control the inflammatory component of the disease, repair of demyelinated lesions is still an unmet need. Despite encouraging results generated in experimental models, several candidates favouring or promoting remyelination have not reached the expected outcomes in clinical trials.
Xin Lin, Yuanhao Yang, Melissa Gresle, Gabriel Cuellar-Partida, Xikun Han, Jim Stankovich, AusLong/Ausimmune Investigators Group , Steve Simpson-Yap, Valery Fuh-Ngwa, Jac Charlesworth, Kathryn P Burdon, Helmut Butzkueven, Bruce V Taylor, Yuan Zhou
doi : 10.1093/brain/awac420
Brain, Volume 146, Issue 6, June 2023, Pages 2464–2475
Understanding how variations in the plasma and brain proteome contribute to multiple sclerosis susceptibility can provide important insights to guide drug repurposing and therapeutic development for the disease. However, the role of genetically predicted protein abundance in multiple sclerosis remains largely unknown.
Jenny A Nij Bijvank, Sam N Hof, Stefanos E Prouskas, Menno M Schoonheim, Bernard M J Uitdehaag, Laurentius J van Rijn, Axel Petzold
doi : 10.1093/brain/awac474
Brain, Volume 146, Issue 6, June 2023, Pages 2476–2488
In multiple sclerosis, remyelination trials have yet to deliver success like that achieved for relapse rates with disease course modifying treatment trials. The challenge is to have a clinical, functional outcome measure. Currently, there are none that have been validated, other than visual evoked potentials in optic neuritis.
Rosa Cortese, Marco Battaglini, Ferran Prados, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Jens Wuerfel, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Dagoberto Callegaro, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Alex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Proebstel, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Luca Carmisciano, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano, Olga Ciccarelli, for the MAGNIMS Study Group
doi : 10.1093/brain/awac480
Brain, Volume 146, Issue 6, June 2023, Pages 2489–2501
MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for MOG antibodies is unavailable or shows uncertain results.
Thomas R Barber, Kinan Muhammed, Daniel Drew, Kevin M Bradley, Daniel R McGowan, Johannes C Klein, Sanjay G Manohar, Michele T M Hu, Masud Husain
doi : 10.1093/brain/awac430
Brain, Volume 146, Issue 6, June 2023, Pages 2502–2511
Idiopathic rapid eye movement sleep behaviour disorder (iRBD) has now been established as an important marker of the prodromal stage of Parkinson’s disease and related synucleinopathies.
Stavros Tsagkaris, Eric K C Yau, Verity McClelland, Apostolos Papandreou, Ata Siddiqui, Daniel E Lumsden, Margaret Kaminska, Eric Guedj, Alexander Hammers, Jean-Pierre Lin
doi : 10.1093/brain/awac439
Brain, Volume 146, Issue 6, June 2023, Pages 2512–2523
There is a lack of imaging markers revealing the functional characteristics of different brain regions in paediatric dystonia. In this observational study, we assessed the utility of [18F]2-fluoro-2-deoxy-D-glucose (FDG)-PET in understanding dystonia pathophysiology by revealing specific resting awake brain glucose metabolism patterns in different childhood dystonia subgroups.
Morgane Darricau, Taxiarchis Katsinelos, Flavio Raschella, Tomislav Milekovic, Louis Crochemore, Qin Li, Grégoire Courtine, William A McEwan, Benjamin Dehay, Erwan Bezard, Vincent Planche
doi : 10.1093/brain/awac428
Brain, Volume 146, Issue 6, June 2023, Pages 2524–2534
Progressive supranuclear palsy is a primary tauopathy affecting both neurons and glia and is responsible for both motor and cognitive symptoms. Recently, it has been suggested that progressive supranuclear palsy tauopathy may spread in the brain from cell to cell in a ‘prion-like’ manner. However, direct experimental evidence of this phenomenon, and its consequences on brain functions, is still lacking in primates.
Giancarlo Pesce, Fanny Artaud, Emmanuel Roze, Isabelle Degaey, Berta Portugal, Thi Thu Ha Nguyen, Agnès Fournier, Marie-Christine Boutron-Ruault, Gianluca Severi, Alexis Elbaz, Marianne Canonico
doi : 10.1093/brain/awac440
Brain, Volume 146, Issue 6, June 2023, Pages 2535–2546
Despite experimental studies suggesting a disease-modifying role of oestrogens, results from epidemiological studies on the relation of reproductive characteristics and hormonal exposures with Parkinson disease in women are conflicting.
Mahmoud-Reza Rafiee, Sara Rohban, Karen Davey, Jernej Ule, Nicholas M Luscombe
doi : 10.1093/brain/awad046
Brain, Volume 146, Issue 6, June 2023, Pages 2547–2556
Valosin-containing protein (VCP) is a hexameric ATPase associated with diverse cellular activities. Genetic mutations in VCP are associated with several forms of muscular and neuronal degeneration, including amyotrophic lateral sclerosis (ALS).
John L Robinson, Sharon X Xie, Daniel R Baer, EunRan Suh, Vivianna M Van Deerlin, Nicholas J Loh, David J Irwin, Corey T McMillan, David A Wolk, Alice Chen-Plotkin, Daniel Weintraub, Theresa Schuck, Virginia M Y Lee, John Q Trojanowski, Edward B Lee
doi : 10.1093/brain/awad059
Brain, Volume 146, Issue 6, June 2023, Pages 2557–2569
Pathologies that are causative for neurodegenerative disease (ND) are also frequently present in unimpaired, older individuals.
Tze How Mok, Akin Nihat, Nour Majbour, Danielle Sequeira, Leah Holm-Mercer, Thomas Coysh, Lee Darwent, Mark Batchelor, Bradley R Groveman, Christina D Orr, Andrew G Hughson, Amanda Heslegrave, Rhiannon Laban, Elena Veleva, Ross W Paterson, Ashvini Keshavan, Jonathan M Schott, Imogen J Swift, Carolin Heller, Jonathan D Rohrer, Alexander Gerhard, Christopher Butler, James B Rowe, Mario Masellis, Miles Chapman, Michael P Lunn, Jan Bieschke, Graham S Jackson, Henrik Zetterberg, Byron Caughey, Peter Rudge, John Collinge, Simon Mead
doi : 10.1093/brain/awad101
Brain, Volume 146, Issue 6, June 2023, Pages 2570–2583
Human prion diseases are remarkable for long incubation times followed typically by rapid clinical decline. Seed amplification assays and neurodegeneration biofluid biomarkers are remarkably useful in the clinical phase, but their potential to predict clinical onset in healthy people remains unclear.
Natalie E Adams, Amirhossein Jafarian, Alistair Perry, Matthew A Rouse, Alexander D Shaw, Alexander G Murley, Thomas E Cope, W Richard Bevan-Jones, Luca Passamonti, Duncan Street, Negin Holland, David Nesbitt, Laura E Hughes, Karl J Friston, James B Rowe
doi : 10.1093/brain/awac471
Brain, Volume 146, Issue 6, June 2023, Pages 2584–2594
Synaptic loss occurs early in many neurodegenerative diseases and contributes to cognitive impairment even in the absence of gross atrophy. Currently, for human disease there are few formal models to explain how cortical networks underlying cognition are affected by synaptic loss.
Shakil Khan, Pabitra Hriday Patra, Hannah Somerfield, Hattaya Benya-Aphikul, Manoj Upadhya, Xuming Zhang
doi : 10.1093/brain/awac462
Brain, Volume 146, Issue 6, June 2023, Pages 2595–2611
TRPA1 channels have been implicated in mechanical and cold hypersensitivity in chronic pain. But how TRPA1 mediates this process is unclear. Here we show that IQ motif containing GTPase activating protein 1 is responsible using a combination of biochemical, molecular, Ca2+ imaging and behavioural approaches
Tzu-Li Yen, Tzyy-Nan Huang, Ming-Hui Lin, Tsan-Ting Hsu, Ming-Hsuan Lu, Pu-Yun Shih, Jacob Ellegood, Jason Lerch, Yi-Ping Hsueh
doi : 10.1093/brain/awac429
Brain, Volume 146, Issue 6, June 2023, Pages 2612–2626
Autism spectrum disorders caused by both genetic and environmental factors are strongly male-biased neuropsychiatric conditions. However, the mechanism underlying the sex bias of autism spectrum disorders remains elusive. Here, we use a mouse model in which the autism-linked gene Cttnbp2 is mutated to explore the potential mechanism underlying the autism sex bias.
Brain, Volume 146, Issue 6, June 2023, Pages 2627–2641
doi : 10.1093/brain/awac442
Brain, Volume 146, Issue 6, June 2023, Pages 2627–2641
Stress is a well-known risk factor to develop a functional neurological disorder, a frequent neuropsychiatric medical condition in which patients experience a variety of disabling neurological symptoms.
Luis Manssuer, Qiong Ding, Yingying Zhang, Hengfeng Gong, Wei Liu, Ruoqi Yang, Chencheng Zhang, Yijie Zhao, Yixin Pan, Shikun Zhan, Dianyou Li, Bomin Sun, Valerie Voon
doi : 10.1093/brain/awac456
Brain, Volume 146, Issue 6, June 2023, Pages 2642–2653
Neurons in the primate lateral habenula fire in response to punishments and are inhibited by rewards. Through its modulation of midbrain monoaminergic activity, the habenula is believed to play an important role in adaptive behavioural responses to punishment and underlie depressive symptoms and their alleviation with ketamine.
Tom Vale
doi : 10.1093/brain/awad083
Brain, Volume 146, Issue 6, June 2023, Pages 2654–2655
Matthew C Kiernan, David Burke, Rachel H Tan
doi : 10.1093/brain/awad021
Brain, Volume 146, Issue 6, June 2023, Pages e34–e35
John Ravits, Julia Stack
doi : 10.1093/brain/awad022
Brain, Volume 146, Issue 6, June 2023, Pages e36–e38
Jan Van den Stock, Chiara Cerami, Alessandra Dodich, Stefano Cappa, Rik Vandenberghe, François-Laurent De Winter, Mathieu Vandenbulcke
doi : 10.1093/brain/awad023
Brain, Volume 146, Issue 6, June 2023, Pages e39–e42
Marcello D’Amelio, Vincenzo Di Lazzaro
doi : 10.1093/brain/awad019
Brain, Volume 146, Issue 6, June 2023, Pages e43–e45,
Giacomo Koch, Alessandro Martorana
doi : 10.1093/brain/awad020
Brain, Volume 146, Issue 6, June 2023, Pages e46–e47
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟